18F-FAPI在小复发灶中浓聚而18F-FDG PET/CT阴性:一例混合型肝细胞-胆管癌
一例70岁男性混合型肝细胞-胆管癌患者,约3个月前接受部分肝切除和放化疗,随访腹部超声发现肝I段新发小低回声病灶疑复发。患者入组比较18F-FDG与18F-FAPI PET/CT的临床试验,18F-FDG无摄取而18F-FAPI呈浓聚,切除后病理证实为复发性混合型肝细胞-胆管癌。
要点
- 混合型肝细胞-胆管癌小复发灶可表现为18F-FDG PET/CT阴性而18F-FAPI浓聚。
- 随访超声发现肝I段新发小低回声病灶,提示复发可能。
- 病灶切除后病理分析证实为复发性混合型肝细胞-胆管癌。
核心结论
- 18F-FAPI PET/CT在小复发灶中呈浓聚而18F-FDG PET/CT阴性,切除后病理证实为复发性混合型肝细胞-胆管癌。
研究设计与样本
- 一例70岁男性混合型肝细胞-胆管癌患者,约3个月前接受部分肝切除和放化疗,因随访超声疑复发而入组比较18F-FDG与18F-FAPI PET/CT的临床试验。
主要发现
- 随访腹部超声在肝I段检出新的小低回声病灶,可能提示复发。
- 与18F-FDG无摄取相比,18F-FAPI PET/CT显示该肝病灶浓聚。
- 病灶切除后病理分析证实为复发性混合型肝细胞-胆管癌。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 70-year-old man presented with combined hepatocellular-cholangiocarcinoma underwent partial hepatectomy and chemoradiotherapy approximately 3 months ago. Follow-up abdominal ultrasound detected a new small lesion with decreased echogenicity in the hepatic segment I, potentially indicating recurrence. The patient was enrolled in a clinical trial of comparison of 18 F-FDG and 18 F-FAPI PET/CT in hepatic lesions. Compared with non- 18 F-FDG avidity, 18 F-FAPI PET/CT showed intense tracer uptake of the hepatic lesion. Resection of the lesion was subsequently performed, and pathologic analysis confirmed the diagnosis of recurrent combined hepatocellular-cholangiocarcinoma.
引用
- Liang J, Zhang J, Song J, et al. Intense 18 F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18 F-FDG PET/CT. Clin Nucl Med. 2024. PMID: 38569540. doi:10.1097/RLU.0000000000005148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。